Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Veru Inc. (VERU)

4.22   -0.08 (-1.86%) 02-14 16:00
Open: 4.31 Pre. Close: 4.3
High: 4.31 Low: 4.19
Volume: 250,552 Market Cap: 275M
Veru Inc is a biopharmaceutical company focused on urology and oncology. It develops prescription products for benign prostatic hyperplasia hot flashes associated with cancer treatment, male infertility and novel chemotherapies for a variety of cancers.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.312 - 4.341 4.341 - 4.365
Low: 4.135 - 4.163 4.163 - 4.186
Close: 4.179 - 4.224 4.224 - 4.262

Technical analysis

as of: 2020-02-14 4:33:32 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 5.54     One year: 6.47
Support: Support1: 3.83    Support2: 3.27
Resistance: Resistance1: 4.74    Resistance2: 5.54
Pivot: 3.93
Moving Average: MA(5): 4.24     MA(20): 4.02
MA(100): 2.76     MA(250): 2.18
MACD: MACD(12,26): 0.21     Signal(9): 0.20
Stochastic oscillator: %K(14,3): 84.11     %D(3): 77.19
RSI: RSI(14): 59.95
52-week: High: 4.74  Low: 1.18  Change(%): 210.3
Average Vol(K): 3-Month: 39217  10-Days: 36091

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
VERU has closed below upper band by 29.8%. Bollinger Bands are 96.9% wider than normal. The large width of the bands suggest high volatility as compared to VERU's normal range. The bands have been in this wide range for 51 bars. This is a sign that the current trend might continue.

Headline News

Veru Inc. (VERU): Q1 2020 Earnings Snapshot
— Veru Inc. (NASDAQ: VERU) reported Q1 2020 loss of $0.05 per share, vs. $0.02 expected. — Revenues grew 66% to $10.6 million, vs. $8.7…

Short Interest in Veru Inc (NASDAQ:VERU) Increases By 36.6%
Veru Inc (NASDAQ:VERU) was the target of a large increase in short interest in the month of October. As of October 31st, there was short interest totalling 72,100 shares, an increase of 36.6% from the September 30th total of 52,800 shares. Currently, 0.2% of the shares of the company are sold short. Based on an […]

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty Generic
Shares Out. (M) 65.07
Shares Float (M) 47.14
% Held by Insiders 24.81
% Held by Institutions 10.24
Shares Short (K) 87
Shares Short P. Month (K)

Stock Financials

EPS -0.190
Book Value (p.s.) 0.500
PEG Ratio -0.28
Profit Margin -37.79
Operating Margin -20.24
Return on Assets (ttm) -7.9
Return on Equity (ttm) -38.9
Qtrly Rev. Growth 67.7
Gross Profit (p.s.) 0.333
Sales Per Share
EBITDA (p.s.) -0.092
Qtrly Earnings Growth
Operating Cash Flow (M) -5.49
Levered Free Cash Flow (M) -6.01

Stock Valuations

P/E -22.21
P/E Growth Ratio -0.02
P/BV 8.44
P/S 8.43
P/CF -50.02

Dividends & Splits

Dividend Yield
Dividend Pay Date 2014-05-06
Ex-Dividend Date 2014-04-27
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.